Regulation 8 Commission Implementing Regulation (EU) 2017/12I1
United Kingdom
Commission Implementing Regulation (EU) 2017/12 regarding the form and content of the applications and requests for the establishment of maximum residue limits in accordance with Regulation (EC) No 470/2009 of the European Parliament and of the Council is amended as follows.
In Article 1—
in paragraph 1, for “European Medicines Agency (EMA)” substitute “ the appropriate authority ”;
after paragraph 2 insert—
“
3In this Regulation, “appropriate authority” is to be read in accordance with Article 2(4) and (5).”.
In Article 2—
in paragraph 1, for “EMA” substitute “ the appropriate authority ”;
in paragraph 3, for “EMA” substitute “ The appropriate authority ”;
after paragraph 3 insert—
“
4In paragraph 1, “appropriate authority” means—
(a)in relation to England, Wales and Scotland, the Secretary of State;
(b)in relation to Northern Ireland, the Department of Agriculture, Environment and Rural Affairs.
5But the appropriate authority is the Secretary of State if consent is given in relation to Northern Ireland by the Department of Agriculture, Environment and Rural Affairs.”.
After Article 3, omit the words from “This Regulation” to “Member States”.
In the Annex—
in paragraph 2, for “EMA” substitute “ appropriate authority ”:
in paragraph B.3.2 of Chapter 2, for “Commission and the EMA” substitute “ appropriate authority ”.
Annotations
Commencement
- I1
Reg. 8 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)(b)